By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

Pandora reported sales ahead of forecast thanks largely to its performance in the U.S., but economic and cost tailwinds look ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

Ticket sales for a major gathering of historic railway vehicles have resumed after they were suspended last week due to ...

(Reuters) - Tesla posted lower sales across five European countries in January, including the United Kingdom and France, as ...

Google’s digital ad sales continued to grow at a healthy clip during the holiday season, but that wasn’t enough to offset ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

A share of Leeds-based Northern Superchargers will be up for grabs when sales of stakes in teams in The Hundred resume on ...

Bandai Namco has announced that Dragon Ball Sparking! Zero sold over five million copies worldwide. The fighting game was ...

Tesla could soon lose its EV sales advantage as Washington lawmakers are taking their third shot at legislation to level the ...